Current progress of aptamer-based molecular imaging

Journal of Nuclear Medicine

Volumn 55, Issue 3, 2014, Pages 353-356

  Wang, Andrew Z ^a   Farokhzad, Omid C ^b,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Aptamer; Aptamers; Molecular diagnostics; Molecular imaging probes

Indexed keywords

A10 GOLD NANOPARTICLE CONJUGATE; A10 SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE CONJUGATE; APTAMER; APTAMER TTA1; AS1411 NANOPARTICLE CONJUGATE; CONTRAST MEDIUM; GOLD NANOPARTICLE; PEGAPTANIB; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; THROMBIN; TTA1 TC 99M; UNCLASSIFIED DRUG; LIGAND;

BINDING AFFINITY; BRAIN CANCER; BREAST CANCER; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG CLEARANCE; DRUG HALF LIFE; ECHOGRAPHY; ISOTOPE LABELING; LIGAND BINDING; MOLECULAR DIAGNOSTICS; MOLECULAR IMAGING; MOLECULAR PROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC IMAGING; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; APTAMERS; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR IMAGING PROBES;

APTAMER; APTAMERS; MOLECULAR DIAGNOSTICS; MOLECULAR IMAGING PROBES;

APTAMERS, NUCLEOTIDE; HUMANS; LIGANDS; MOLECULAR IMAGING; MOLECULAR PROBES;

EID: 84899491559     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.126144     Document Type: Review

References (20)

1. Kong RM, Zhang XB, Chen Z, Tan W. Aptamer-assembled nanomaterials for biosensing and biomedical applications. Small. 2011;7:2428-2436.
2. Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature. 1990;346:818-822.
3. Hu M, Zhang K. The application of aptamers in cancer research: an up-to-date review. Future Oncol. 2013;9:369-376.
4. Hong P, Li W, Li J. Applications of aptasensors in clinical diagnostics. Sensors (Basel). 2012;12:1181-1193.
5. Cruz-Aguado JA, Penner G. Fluorescence polarization based displacement assay for the determination of small molecules with aptamers. Anal Chem. 2008;80: 8853-8855.
6. Kraemer S, Vaught JD, Bock C, et al. From SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assay. PLoS ONE. 2011;6:e26332.
7. Ni X, Castanares M, Mukherjee A, Lupold SE. Nucleic acid aptamers: clinical applications and promising new horizons. Curr Med Chem. 2011;18:4206-4214.
8. Hong H, Goel S, Zhang Y, Cai W. Molecular imaging with nucleic acid aptamers. Curr Med Chem. 2011;18:4195-4205.
9. Shi H, He X, Wang K, et al. Activatable aptamer probe for contrast-enhanced in vivo cancer imaging based on cell membrane protein-triggered conformation alteration. Proc Natl Acad Sci USA. 2011;108:3900-3905.
10. Wu C, Chen T, Han D, et al. Engineering of switchable aptamer micelle flares for molecular imaging in living cells. ACS Nano. 2013;7:5724-5731.
11. Wang AZ, Bagalkot V, Vasilliou CC, et al. Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy. ChemMedChem. 2008;3:1311-1315.
12. Yigit MV, Mazumdar D, Lu Y. MRI detection of thrombin with aptamer functionalized superparamagnetic iron oxide nanoparticles. Bioconjug Chem. 2008;19: 412-417.
13. Kim D, Jeong YY, Jon S. A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. ACS Nano. 2010;4:3689-3696.
14. Unnikrishnan S, Klibanov AL. Microbubbles as ultrasound contrast agents for molecular imaging: preparation and application. AJR. 2012;199:292-299.
15. Wang CH, Huang YF, Yeh CK. Aptamer-conjugated nanobubbles for targeted ultrasound molecular imaging. Langmuir. 2011;27:6971-6976.
16. Nakatsuka MA, Mattrey RF, Esener SC, Cha JN, Goodwin AP. Aptamercrosslinked microbubbles: smart contrast agents for thrombin-activated ultrasound imaging. Adv Mater. 2012;24:6010-6016.
17. Winnard PT Jr, Pathak AP, Dhara S, Cho SY, Raman V, Pomper MG. Molecular imaging of metastatic potential. J Nucl Med. 2008;49(suppl 2):96S-112S.
18. Pieve CD, Perkins AC, Missailidis S. Anti-MUC1 aptamers: radiolabelling with 99mTc and biodistribution in MCF-7 tumour-bearing mice. Nucl Med Biol. 2009;36:703-710.
19. Hwang do W, Ko HY, Lee JH, et al. A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer. J Nucl Med. 2010;51: 98-105.
20. Tesmer VM, Lennarz S, Mayer G, Tesmer JJ. Molecular mechanism for inhibition of g protein-coupled receptor kinase 2 by a selective RNA aptamer. Structure. 2012;20:1300-1309.